Brii Biosciences
Manufacturing · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
110 N Corcoran St Ste 5110- ONE, Durham,...Phone Number
(919) 240-5605Website
www.briibio.comRevenue
<$5 MillionStock Symbol
2137Industry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Brii Biosciences
Brii Biosciences is a biotechnology company focused on developing innovative treatment options for infectious diseases, particularly in areas with high unmet medical needs. The company aims to bring first-in-class and different-in-class therapies to patients, including those affected by HIV, hepatitis B, and COVID-19. With a commitment to scientific innovation and public health, Brii Biosciences collaborates with various partners to advance its research and development pipeline. Its primary clients include healthcare providers and patients in China and beyond, seeking effective solutions for challenging health conditions.Explore more
Brii Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Brii Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Brii Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Brii Biosciences
Earning: See what the market has to say on Brii Biosciences recently announced quarterly report
Brii Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Brii Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Brii Biosciences launches new products
Click to see if Brii Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Brii Biosciences has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Brii Biosciences
Compare insights from companies similar to Brii Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Brii Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Brii Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Brii Biosciences.
Brii Biosciences financials insights
Gather financial insights about Brii Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series C
$155M
Brii Biosciences Tech Stack
A closer look at the technologies used by Brii Biosciences
Most Recent Scoops
Person-Based
Lawsuits, Legal Affairs
Open Position
Person-Based
Person-Based
Partnership, Research & Development, Sustainability
Open Position
Brii Biosciences News & Media
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
- Final results from the ENSURE study demonstrate that the addition of elebsiran resulted in a higher functional cure rate compared with pegylated interferon alfa (PEG-IFNα) alone - Data from Cohort 4 suggested that participants responding to prior BRII‑179 treatment achieved the most...Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
- Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes, with most HBsAg rebounds <10 IU/mL and HBV DNA rebound infrequent and not associated with clinically significant ALT elevation....Brii Biosciences Limited (BRIBF) Q4 2025 Earnings Call Transcript
Brii Biosciences Limited (BRIBF) Q4 2025 Earnings Call March 20, 2026 8:30 AM EDTCompany ParticipantsKathy YuAnkang Li - Chief Financial & Strategy...Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results
Advancing HBV Functional Cure Toward Key Phase 2b Data Readouts Increasing Discovery Efforts to Drive Long-term Value Creation Strong Cash Position Supporting Strategic Priorities Upcoming Conference Calls: English Session: March 20 at 8:30 p.m. HKT / 8:30 a.m. ET Chinese Session: March...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Brii Biosciences
Sign Up For FreeTo access detailed company insights
Brii Biosciences is a biotechnology company focused on developing innovative treatment options for infectious diseases, particularly in areas with high unmet medical needs. The company aims to bring first-in-class and different-in-class therapies to patients, including those affected by HIV, hepatitis B, and COVID-19. With a commitment to scientifi... Read More
